TIDMKMK

RNS Number : 0162O

Kromek Group PLC

04 February 2016

4 February 2016

Kromek Group plc

("Kromek" or the "Company")

Capital Markets Day

Kromek (AIM: KMK), a radiation detection technology company focusing on the medical, security and nuclear markets, is hosting a Capital Markets Day, at its headquarters in Sedgefield, today.

The briefing will provide investors with an opportunity to enhance their understanding of Kromek's business through a tour of the manufacturing facility and a presentation will be given by the senior management of the Company.

No material price-sensitive information will be disclosed and no information relating to current trading will be provided.

Copies of the presentation will be made available on the Kromek website: www.kromek.com.

Enquiries

 
 Kromek Group plc 
--------------------------------  --------------- 
 Arnab Basu, CEO                   +44 (0)1740 
  Derek Bulmer, CFO                 626 060 
--------------------------------  --------------- 
 
 Cenkos Securities plc 
--------------------------------  --------------- 
 Bobbie Hilliam (NOMAD) 
  Julian Morse, Michael Johnson    +44 (0)20 7397 
  (Sales)                           8900 
--------------------------------  --------------- 
 
 Luther Pendragon Ltd 
--------------------------------  --------------- 
 Harry Chathli, Claire Norbury,    +44 (0)20 7618 
  Alexis Gore                       9100 
--------------------------------  ---------------

About Kromek Group plc

Kromek Group plc is a UK technology company (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT"). Using its core CZT technology, Kromek designs develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.

The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.

The Group's business model provides a vertically integrated technology offering to customers, from the growth of CZT crystals to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").

The Group has operations in the UK, Germany and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.

Currently, the Group has over a hundred full time employees across its global operations. Further information on Kromek Group is available at www.kromek.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCFXLLBQLFFBBV

(END) Dow Jones Newswires

February 04, 2016 02:00 ET (07:00 GMT)

Kromek (LSE:KMK)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Kromek Charts.
Kromek (LSE:KMK)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Kromek Charts.